In line with such an assumption, we confirmed data revealing a relationship of Fetuin-B to estimates of obesity [15, 18], liver fat [16–18], whole body [14, 17, 18], and myocellular insulin resistance [17], even if this was not described in all cohorts [15, 19]. Here, FETUB is linked to obesity due to melanocortin 4 receptor deficiency.